RARγ overexpression contributed to the multidrug chemoresistance of cholangiocarcinoma cells, which, in part, was related to P glycoprotein upregulation via activation of the Wnt/β-catenin pathway. This evidence concerns the gene RARG and cholangiocarcinoma.